Author

Xiazi I Qiu

Observed names: Qiu, Xiazi I, Xiazi Qiu

Observed institutions: University of Kansas, AbbVie (United States)

ORCID: 0000-0002-8397-2168

Observed ORCID: 0000-0002-8397-2168

OpenAlex ID: A5083302714

Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

2024 · Elisabet A. Frick, Valur Emilsson, et al. · Nature Aging · 42

2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)

2023 · Matt Szapacs, Wenying Jian, et al. · Bioanalysis · 22

2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 – Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization

2023 · Giane Sumner, Steve Keller, et al. · Bioanalysis · 16

Comparison of Three Parallelism Assessment Methods of Biomarker Quantification by LC-MS/MS: a Case Study of the Bioanalysis of Creatinine in Human Urine Samples

2022 · Xiazi I Qiu, John P Savaryn, et al. · Bioanalysis · 10

Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?

2025 · Yan G. Ni, Lauren F. Stevenson, et al. · The AAPS Journal · 6

Signature Peptide Selection Workflow for Biomarker Quantification Using LC–MS-Based Targeted Proteomics

2023 · Xiazi I Qiu, Kenneth J Ruterbories, et al. · Bioanalysis · 6

Quantification of Neonatal Fc Receptor and Beta-2 Microglobulin in Human Liver Tissues by Ultraperformancse Liquid Chromatography–Multiple Reaction Monitoring–based Targeted Quantitative Proteomics for Applications in Biotherapeutic Physiologically-based Pharmacokinetic Models

2020 · Xiazi Qiu, Michael Zhuo Wang · Drug Metabolism and Disposition · 5

Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development

2026 · Carmen Fernández-Metzler, Karen J. Quadrini, et al. · Bioanalysis · 3

Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

2024 · Elisabet A. Frick, Valur Emilsson, et al. · Nature Aging · 3

Fit-for-purpose LC-MS/MS quantification of leukotoxin and leukotoxin diol in mouse plasma without sample pre-concentration

2021 · John Paul Savaryn, Xiazi Qiu, et al. · Journal of Chromatography B · 3

Development of a UPLC-MRM-based targeted proteomic method to profile subcellular organelle marker proteins from human liver tissues

2022 · Xiazi Qiu, Laura M. Doyle, et al. · Scientific Reports · 2

Works count: 13

Citation count: 118

H-index: 6

I10-index: 4